Aspirin increases bleeding risk in older stroke patients: study

June 14, 2017
Credit: CC0 Public Domain

Long-term, daily use of aspirin to prevent blood clots in very elderly patients leads to an increased risk of serious or fatal internal bleeding, researchers said Wednesday.

Heartburn medication would allows people 75 years and older to keep the preventative benefits of aspirin while avoiding its dangerous side-effects, they reported in the medical journal The Lancet.

Even among people with no history of heart problems or stroke, the risk of goes up with age for aspirin users, other research has shown.

Roughly half of all adults 75 and over in the US and Europe take small daily doses of aspirin—ranging from 75 to 150 milligrams—or other clot-inhibiting drugs.

A normal dose for a headache is 325 to 600 mg.

Lifelong treatment with such medications is especially recommended for patients who have suffered a heart attack or stroke.

But the clinical tests underlying these recommendations involved mostly patients younger than 75 who had taken aspirin for only a couple years.

As a result, how much the risk of bleeding might rise with age was largely unknown.

'Reassurance'

To find out more, Peter Rothwell from the University of Oxford led a team of researchers in examining medical records for more than 3,000 patients who had had a stroke or , and taken daily aspirin or its equivalent for many years.

Half the patients were 75 or older at the start of the period covered by the study.

Over the following decade, 314 patients were admitted to hospital for bleeding.

The risk of that happening increased sharply with age: for patients under 65, the annual rate of hospital admissions due to bleeding was 1.5 percent; for patients 75 to 84, the rate rose to 3.5 percent; and for those over 85 it was five percent.

The chances that bleeding was disabling or fatal, while lower, increased in roughly the same proportions across the different age groups.

"We have known for some time that aspirin increases the risk of bleeding in elderly patients," Rothwell said in a statement. "But our study gives us a much clearer understanding of the size of the increased risk and the severity of the consequences."

The researchers suggest that taking (PPI)—a kind of heartburn medication—could reduce bleeding in the upper gastrointestinal tract by up to 90 percent.

"There is some evidence that long-term PPI use might have some small risks," Rothwell noted.

But "the new data should provide reassurance that the benefits of PPI use at older age outweigh the risks."

Treatment programmes should be reviewed every three to five years in very who take aspirin and PPIs together, the authors said.

Several experts not involved in the study praised its methodology and endorsed its conclusions.

"It is clear from the data presented that—in the over-75s—taking PPI along with was associated with a reduced likelihood of bleeding," said Tony Fox, a professor in the Pharmaceutical Medicine Group at King's College London.

Explore further: Long-term aspirin use doesn't lower risk of stroke for some a-fib patients

Related Stories

Long-term aspirin use doesn't lower risk of stroke for some a-fib patients

May 13, 2017
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City found that using long-term aspirin therapy to prevent strokes among patients who are considered to be at low risk for stroke ...

Aspirin does little or nothing for hard arteries, researchers find

June 5, 2017
For decades, aspirin has been widely used to reduce the risk of cardiovascular problems. Now, a team led by a University of Florida Health researcher has found that aspirin may provide little or no benefit for certain patients ...

Major bleeding risk from drugs similar in elderly

April 17, 2017
(HealthDay)—The risk of major bleeding is similar for older patients with atrial fibrillation taking either antiplatelet or anticoagulant drugs, according to a review published online April 10 in the Journal of Thrombosis ...

Blood thinner and aspirin show similar bleeding risk in coronary patients

March 20, 2017
Substituting rivaroxaban for aspirin in patients with acute coronary syndromes (ACS) appears to cause no significant increase in bleeding risk, according to a study led by scientists from the Duke Clinical Research Institute ...

Aspirin therapy may not help patients with peripheral vascular disease, researchers find

April 12, 2017
Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found.

Benefits of daily aspirin outweigh risk to stomach: study

November 30, 2016
Stomach bleeds caused by aspirin are considerably less serious than the spontaneous bleeds that can occur in people not taking the drug, concludes a study led by Cardiff University.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.